参考文献:1.Flierl, M.A., P.F. Stahel, B.M. Touban, K.M. Beauchamp, S.J. Morgan, W.R. Smith, and K.R. Ipaktchi. 2009. Bench-to-bedside review: burn-induced cerebral inflammation鈥揳 neglected entity? Critical Care 13: 215.View Article PubMed Central PubMed 2.Bird, M.D., and E.J. Kovacs. 2008. Organ-specific inflammation following acute ethanol and burn injury. Journal of Leukocyte Biology 84: 607鈥?13.View Article PubMed Central PubMed 3.Hotchkiss, R.S., C.M. Coopersmith, J.E. McDunn, and T.A. Ferguson. 2009. The sepsis seesaw: tilting toward immune-suppression. Nature Medicine 15: 496鈥?97.View Article PubMed Central PubMed 4.Boomer, J.S., K. To, K.C. Chang, O. Takasu, D.F. Osborne, A.H. Walton, T.L. Bricker, S.D. Jarman 2nd, D. Kreisel, A.S. Krupnick, A. Srivastava, P.E. Swanson, J.M. Green, and R.S. Hotchkiss. 2011. Immuno-suppression in patients who die of sepsis and multiple organ failure. JAMA 306: 2594鈥?605.View Article PubMed Central PubMed 5.Shi, W.W. 2010. The effect and mechanism of resveratrol potentiating the activity of anti-tumor drugs. Peking Union Medical College Hospital. 6.Zong, Y., L. Sun, B. Liu, Y.S. Deng, D. Zhan, Y.L. Chen, Y. He, J. Liu, Z.J. Zhang, J. Sun, and D. Lu. 2012. Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 264.7 macrophage cells. PLoS One 7: e44107.View Article PubMed Central PubMed 7.Baur, J.A., K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, V.V. Prabhu, J.S. Allard, G. Lopez-Lluch, K. Lewis, P.J. Pistell, S. Poosala, K.G. Becker, O. Boss, D. Gwinn, M. Wang, S. Ramaswamy, K.W. Fishbein, R.G. Spencer, E.G. Lakatta, D. Le Couteur, R.J. Shaw, P. Navas, P. Puigserver, D.K. Ingram, R. de Cabo, and D.A. Sinclair. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337鈥?42.View Article PubMed 8.Liu, B., and Z. Zhou. 2013. Activation of SIRT1 by resveratrol requires lamin A. Aging (Albany NY) 5: 94鈥?5. 9.Pearson, K.J., J.A. Baur, K.N. Lewis, L. Peshkin, N.L. Price, N. Labinskyy, W.R. Swindell, D. Kamara, R.K. Minor, E. Perez, H.A. Jamieson, Y. Zhang, S.R. Dunn, K. Sharma, N. Pleshko, L.A. Woollett, A. Csiszar, Y. Ikeno, D. Le Counteur, P.J. Elliott, K.G. Becker, P. Navas, D.K. Ingram, N.S. Wolf, Z. Ungvari, D.A. Sinclair, and R. de Cabo. 2008. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metabolism 8: 157鈥?68.View Article PubMed Central PubMed 10.Borra, M.T., B.C. Smith, and J.M. Denu. 2005. Mechanism of human SIRT1 activation by resveratrol. Biological Chemistry 280: 17187鈥?7195.View Article 11.Hisahara, S., S. Chiba, H. Matsumoto, and Y. Horio. 2005. Transcriptional regulation of neuronal genes and its effect on neural functions DNA-dependent histone deacetylase SIRT1 (Sir2). Pharmacological Sciences 98: 200鈥?04.View Article 12.Leibiger, I.B., and P.O. Berggren. 2006. Sirt1: a metabolic master switch that modulates lifespan. Nature Medicine 12: 34鈥?6.View Article PubMed 13.Bordone, L., and L. Guarente. 2005. Caloric restriction, SIRT1 and metabolish: understanding longevity. Nature Reviews Molecular Cell Biology 6: 298鈥?05.View Article PubMed 14.Chua, K.F., R. Mostoslavsky, D.B. Lombard, W.W. Pang, S. Saito, S. Franco, D. Kaushal, H.L. Cheng, M.R. Fischer, N. Stokes, M.M. Murphy, E. Appella, and F.W. Alt. 2005. Mammalian SIRT1 limits replicative lifespan in response to chronic genotoxic stress. Cell Metabolism 2: 67鈥?6.View Article PubMed 15.Wang, T., J. Gu, P.F. Wu, F. Wang, Z. Xiong, Y.J. Yang, W.N. Wu, L.D. Dong, and J.G. Chen. 2009. Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation. Free Radical Biology and Medicine 47: 229鈥?40.View Article PubMed 16.Han, J.J., W. Liu, and Y.P. Bi. 2008. Advances in resveratrol studies. Chinese Journal of Biotechnology 24: 1851鈥?859.View Article PubMed 17.Chen, H.X., X.X. Zhu, X. Xu, Y. Xue, X. Yang, and H.J. Zou. 2013. Research progress of Sirt1 in immune regulation. Progress in Modern Biomedicine 13: 2570鈥?573. 18.Niederer, F., C. Ospelt, F. Brentano, M.O. Hottiger, R.E. Gay, S. Gay, M. Detmar, and D. Kyburz. 2011. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Annals of the Rheumatic Diseases 70: 1866鈥?873.View Article PubMed 19.Stein, S., N. Sch盲fer, A. Breitenstein, C. Besler, S. Winnik, C. Lohmann, K. Heinrich, C.E. Brokopp, C. Handschin, U. Landmesser, F.C. Tanner, T.F. L眉scher, and C.M. Matter. 2010. SIRT1 reduce endothelial activation without affecting vascular function in ApoE-/-mice. Aging (Albany NY) 2: 353鈥?60. 20.Maria, J., R.D. Basterrechea, and M.D. Fernando Stein. 2000. Special article: the association of sepsis with multiple organ dysfunction syndrome. Seminars in Pediatric Infectious Diseases 1: 68鈥?2. 21.Olholm, J., S.K. Paulsen, K.B. Cullberg, B. Richelsen, and S.B. Pedersen. 2010. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. International Journal of Obesity 34: 1546鈥?553.View Article PubMed 22.Wang, S.J., Q.Y. Bo, X.H. Zhao, X. Yang, Z.F. Chi, and X.W. Liu. 2013. Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling. Brain Research 1492: 122鈥?29.View Article PubMed 23.Gualdoni, A., J. Kovarik, J. Hofer, F. Dose, M. Pignitter, D. Doberer, P. Steinberger, V. Somoza, M. Wolzt, and G.J. Zlabinger. 2014. Resveratrol enhances TNF-伪production inhuman monocytes bacterial stimulation. Biochemistry and Biophysics Acta 1840: 95鈥?05.View Article 24.Li, N., X. Hu, Y. Liu, Y. Wang, J. Liu, W. Cai, X. Bai, X. Zhu, J. Han, and D. Hu. 2013. Systemic inflammatory responses and multiple organ dysfunction syndrome following skin burn wound and pseudomonas aeruginosa infection in mice. Shock 40: 152鈥?59.View Article PubMed 25.Sulaiman, M., M.J. Matta, N.R. Sunderesan, M.P. Gupta, M. Periasamy, and M. Gupta. 2010. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. American Journal of Physiology. Heart and Circulatory Physiology 298: H833鈥揌843.View Article PubMed Central PubMed 26.Yoshizaki, T., S. Schenk, T. Imamura, J.L. Babendure, N. Sonoda, E.J. Bae, D.Y. Oh, M. Lu, J.C. Milne, C. Westphal, G. Bandyopadhyay, and J.M. Olefsky. 2010. SIRT1 inhabits inflammatory pathways in macrophages and modulates insulin sensitivity. American Journal of Physiology - Endocrinology and Metabolism 298: E419鈥揈428.View Article PubMed Central PubMed
作者单位:Ke Tao (1) Xiaozhi Bai (1) Wenbin Jia (1) Yang Liu (1) Xiongxiang Zhu (1) Juntao Han (1) Maolong Dong (1) Jun Li (1) Dongdong Chen (2) Dahai Hu (1)
1. Department of Burn and Cutaneous Surgery, Xijing Hospital, The Fourth Military Medical University, No. 127 West Changle Road, Xi鈥?an, 710032, Shaanxi Province, People鈥檚 Republic of China 2. Department of Neurology, No. 451 Hospital of Chinese People鈥檚 Liberation Army, Xi鈥?an, 710032, Shaanxi Province, People鈥檚 Republic of China
刊物类别:Medicine
刊物主题:Medicine & Public Health Rheumatology Internal Medicine Pharmacology and Toxicology Pathology